` HVO (hVIVO PLC) vs FTSE All Share Index Comparison - Alpha Spread

HVO
vs
F
FTSE All Share Index

Over the past 12 months, HVO has outperformed FTSE All Share Index, delivering a return of -64% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
HVO vs FTSE All Share Index

Loading
HVO
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
HVO vs FTSE All Share Index

Loading
HVO
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
HVO vs FTSE All Share Index

Loading
HVO
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
hVIVO PLC vs Peers

FTSE All Share Index
HVO
0KHE
TMO
DHR
LONN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

hVIVO PLC
Glance View

hVIVO PLC provides pharmaceutical development services. The firm is engaged in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The company provides end-to-end early clinical development services to its client base, which includes global biopharma companies. The company offers a portfolio of approximately 10+ human challenge models to test a range of infectious and respiratory disease products, challenge agent manufacturing, specialist drug development, and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The company offers additional clinical field trial services, such as patient recruitment and clinical trial site services. The company runs challenge studies in from its Whitechapel quarantine clinic, and its QMB clinic with its specialized on-site virology and immunology laboratory.

HVO Intrinsic Value
11.35 GBX
Undervaluation 42%
Intrinsic Value
Price
Back to Top